APO-GUANFACINE XR
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-GUANFACINE XR in Canada?
Yes. APO-GUANFACINE XR 4MG has an active shortage reported to Health Canada (last updated August 6, 2026).
Why is APO-GUANFACINE XR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-GUANFACINE XR be available again?
The estimated resolution date (August 7, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
INTUNIV XR
Extended-ReleaseTAKEDA CANADA INC
PRO-GUANFACINE XR
Extended-ReleasePRO DOC LIMITEE
JAMP GUANFACINE XR
Extended-ReleaseJAMP PHARMA CORPORATION
AG-GUANFACINE XR
Extended-ReleaseANGITA PHARMA INC.
SANDOZ GUANFACINE XR
Extended-ReleaseSANDOZ CANADA INCORPORATED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-08-07
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02523752
Strength
4MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Active Ingredient
GUANFACINE
Tier
Unrated
Last Updated
2026-08-06
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178